Internal Medicine, Infectious Disease · Trenton, NJ
NPI
1861562688
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
40 Fuld St, Ste 305
Trenton, NJ, 08638
Phone (609) 394-6338
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
1,033 services
Medicare patients, 2024
406
Average age 72
Drug cost, 2024
$789K
462 prescriptions
Company payments, 2024
$14.53
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rajashree Anandakrishnan was code 99232 (hospital e&m - subsequent), 622 times for 276 patients. In total Rajashree Anandakrishnan billed 1,033 services in 15 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 622 | 276 | $66.79 | $42K |
| 99222 Hospital E&M - Initial | Facility | 134 | 128 | $106.88 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 127 | 89 | $97.73 | $12K |
| 99223 Hospital E&M - Initial | Facility | 87 | 82 | $146.48 | $13K |
| 99213 Office E&M - Established | Office | 26 | 17 | $74.04 | $1,925 |
By year: 2022 $97K for 1,327 services; 2023 $76K for 997 services; 2024 $85K for 1,033 services.
Medicare prescription drug claims, 2024
In 2024, the drug Rajashree Anandakrishnan prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 64 prescriptions and refills. In total Rajashree Anandakrishnan wrote 462 Medicare prescriptions that cost $789K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 64 | 64 | Under 11 | $259K |
| Darunavir Generic | 33 | 33 | Under 11 | $30K |
| Ritonavir Generic | 30 | 37 | Under 11 | $5,054 |
| Complera Emtricita/Rilpivirine/Tenof Df | 28 | 28 | Under 11 | $92K |
| Juluca Dolutegravir/Rilpivirine | 25 | 25 | Under 11 | $92K |
| Isentress Raltegravir Potassium | 24 | 24 | Under 11 | $47K |
| Valacyclovir Valacyclovir Hcl | 23 | 23 | Under 11 | $571 |
| Cefazolin Sodium Generic | 17 | 17 | Under 11 | $526 |
| Prezcobix Darunavir/Cobicistat | 15 | 15 | Under 11 | $36K |
| Dovato Dolutegravir Sodium/Lamivudine | 15 | 15 | Under 11 | $43K |
| Abacavir-Lamivudine Abacavir Sulfate/Lamivudine | 15 | 21 | Under 11 | $6,638 |
| Tivicay Dolutegravir Sodium | 13 | 13 | Under 11 | $28K |
| Ceftriaxone Ceftriaxone Sodium | 13 | 13 | Under 11 | $455 |
| Edurant Rilpivirine Hcl | 12 | 12 | Under 11 | $18K |
| Efavirenz-Emtric-Tenofov Disop Efavirenz/Emtricit/Tenofovr Df | 11 | 11 | Under 11 | $4,786 |
Brand drugs: 230 claims; generic drugs: 232 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Rajashree Anandakrishnan $14.53 ($14.53 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $14.53.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $14.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.